What's the Delay In Support for Vical? - trackseekingalpha

Sign Up | Log In | What is SocialPicks?

What's the Delay In Support for Vical?
Jul 26, 2009 09:49 AM UTC

trackseekingalpha

Return	Risk
-11.17%	HIGH

Tracked Blogger

Profile & Performance

Subscribe to author

Symbol	Sentiment	Start	Return	Closed
NVS	n/a
SNY	n/a
GSK	n/a
AU	n/a
AZN	n/a
VICL	n/a

Via Long Investment Ideas from Seeking Alpha:

In the chicken, egg and pig story, what is the delay in the Navy’s support for Vical’s (VICL) DNA based H1N1 swine flu vaccine?

Bloomberg’s “Swine Flu Vaccine Delays Won’t Slow October Timetable” and “First Trials of Swine Flu Vaccine Begin in Australia” report that the US has contracted with five pharmaceutical companies to stockpile swine flu (H1N1) vaccines: Novartis (NVS) 45%, Sanofi Aventis (SNY) 26%, CSL (CSL:AU) 19%, and AstraZeneca (AZN) and GlaxoSmithKline (GSK) the remainder. Of these suppliers, only Australian based CSL is ready to start clinical trials. The others are incurring delays caused by production inefficiencies.

Read the rest of original post »

Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.